Theravance Biopharma Inc (TBPH)
Stock-Based Compensation
$5.99M
Quarterly · Period ending: · USD
TBPH Stock-Based Compensation
Latest reported$5.99Mperiod ending
Latest reported$5.99Mperiod ending
TBPH Quarterly Stock-Based Comp ($5.24M → $5.99M)
Quarterly stock-based compensation
High-resolution chart · PNG
TBPH stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 5,990,000 | |
| 4,504,000 | |
| 4,480,000 | |
| 4,576,000 | |
| 4,543,000 | |
| 4,877,000 | |
| 5,826,000 | |
| 4,963,000 | |
| 5,375,000 | |
| 5,229,000 | |
| 5,824,000 | |
| 6,262,000 | |
| 6,264,000 | |
| 7,021,000 | |
| 6,950,000 | |
| 8,530,000 | |
| 9,709,000 | |
| 14,545,000 | |
| 16,918,000 | |
| 14,370,000 | |
| 14,941,000 | |
| 15,832,000 | |
| 0 | |
| 15,564,000 | |
| 0 | |
| 15,276,000 | |
| 23,912,000 | |
| 13,019,000 | |
| 11,299,000 | |
| 12,220,000 | |
| 11,714,000 | |
| 11,746,000 | |
| 13,855,000 | |
| 13,998,000 | |
| 17,793,000 | |
| 10,685,000 | |
| 10,398,000 | |
| 10,269,000 | |
| 10,040,000 | |
| 9,895,000 | |
| 9,904,000 | |
| 11,330,000 | |
| 11,511,000 | |
| 12,250,000 | |
| 14,663,000 | |
| 15,626,000 | |
| 14,420,000 | |
| 9,350,000 | |
| 6,763,000 | |
| 12,701,000 | |
| 5,159,000 | |
| 5,594,000 | |
| 6,207,000 | |
| 5,516,000 | |
| 5,171,000 | |
| 5,241,000 |